MedPath

Investigation of the immunogenicity and durability of second COVID-19 vaccine booster dose and their associations with the background factors

Not Applicable
Conditions
Regardless of the type of disease
Registration Number
JPRN-UMIN000048396
Lead Sponsor
Department of Pulmonology and Gerontology, Graduate School of Medicine, Yamaguchi University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1) Those who do not wish to be vaccinated with second COVID-19 vaccine booster dose. 2) Those who are judged to be inappropriate for registration at the discretion of the doctor in charge.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison of immune response between residents of long-term care facilities and outpatients at four weeks and 24 weeks after the second COVID-19 vaccine booster dose.
Secondary Outcome Measures
NameTimeMethod
The assessment of associations vaccine immunogenicity at four weeks and 24 weeks after the second COVID-19 vaccine booster dose with the clinical background of participants.
© Copyright 2025. All Rights Reserved by MedPath